1. Home
  2. Pharma & Healthcare
  3. Global Hyperkalemia Treatment Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Hyperkalemia Treatment Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 130 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Hyperkalemia Treatment market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Hyperkalemia Treatment market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Hyperkalemia Treatment in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Patiromer
Sodium Zirconium Cyclosilicate

Market Snapshot, By Application
Hospital Pharmacy
Retail Pharmacy

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Vifor Pharma
Sanofi
CMP Pharma
Belcher Pharmaceuticals
Astrazeneca

The study objectives of this report are:
To study and analyze the global Hyperkalemia Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Hyperkalemia Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Hyperkalemia Treatment manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hyperkalemia Treatment market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Hyperkalemia Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hyperkalemia Treatment are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Hyperkalemia Treatment Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Hyperkalemia Treatment Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Hyperkalemia Treatment

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Hyperkalemia Treatment Sales Channel and Distributors Analysis
3.3.1 Hyperkalemia Treatment Sales Channel
3.3.2 Hyperkalemia Treatment Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Hyperkalemia Treatment Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Hyperkalemia Treatment Type Introduction
4.1.1 Patiromer
4.1.2 Sodium Zirconium Cyclosilicate
4.2 Global Hyperkalemia Treatment Sales by Type 2016-2021
4.3 Global Hyperkalemia Treatment Revenue by Type 2016-2021
4.4 Global Hyperkalemia Treatment Price by Type 2016-2021

5 Market Segment: by Application
5.1 Hyperkalemia Treatment Type Introduction
5.1.1 Hospital Pharmacy
5.1.2 Retail Pharmacy
5.2 Global Hyperkalemia Treatment Sales by Application 2016-2021
5.3 Global Hyperkalemia Treatment Revenue by Application 2016-2021
5.4 Global Hyperkalemia Treatment Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Hyperkalemia Treatment Market by Region
6.1.1 Global Hyperkalemia Treatment Sales by Regions
6.1.2 Global Hyperkalemia Treatment Revenue by Regions
6.2 North America Hyperkalemia Treatment Market 2016-2021
6.3 Europe Hyperkalemia Treatment Market 2016-2021
6.4 Asia Pacific Hyperkalemia Treatment Market 2016-2021
6.5 South America Hyperkalemia Treatment Market 2016-2021
6.6 Middle East and Africa Hyperkalemia Treatment Market 2016-2021

7 North America
7.1 North America Hyperkalemia Treatment Market by Country 2016-2021
7.1.1 North America Hyperkalemia Treatment Sales by Country
7.1.2 North America Hyperkalemia Treatment Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Hyperkalemia Treatment Market by Country 2016-2021
8.1.1 Europe Hyperkalemia Treatment Sales by Country
8.1.2 Europe Hyperkalemia Treatment Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Hyperkalemia Treatment Market by Country 2016-2021
9.1.1 Asia Pacific Hyperkalemia Treatment Sales by Country
9.1.2 Asia Pacific Hyperkalemia Treatment Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Hyperkalemia Treatment Market by Country 2016-2021
10.1.1 South America Hyperkalemia Treatment Sales by Country
10.1.2 South America Hyperkalemia Treatment Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Hyperkalemia Treatment Market by Country 2016-2021
11.1.1 Middle East and Africa Hyperkalemia Treatment Sales by Country
11.1.2 Middle East and Africa Hyperkalemia Treatment Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Vifor Pharma
12.1.1 Vifor Pharma Company Information
12.1.2 Vifor Pharma Hyperkalemia Treatment Product Portfolio, Specification and Application
12.1.3 Vifor Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Vifor Pharma Key Development
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Hyperkalemia Treatment Product Portfolio, Specification and Application
12.2.3 Sanofi Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sanofi Key Development
12.3 CMP Pharma
12.3.1 CMP Pharma Company Information
12.3.2 CMP Pharma Hyperkalemia Treatment Product Portfolio, Specification and Application
12.3.3 CMP Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 CMP Pharma Key Development
12.4 Belcher Pharmaceuticals
12.4.1 Belcher Pharmaceuticals Company Information
12.4.2 Belcher Pharmaceuticals Hyperkalemia Treatment Product Portfolio, Specification and Application
12.4.3 Belcher Pharmaceuticals Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Belcher Pharmaceuticals Key Development
12.5 Astrazeneca
12.5.1 Astrazeneca Company Information
12.5.2 Astrazeneca Hyperkalemia Treatment Product Portfolio, Specification and Application
12.5.3 Astrazeneca Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Astrazeneca Key Development

13 Global Hyperkalemia Treatment Market Forecast by Region by Type and by Application
13.1 Global Hyperkalemia Treatment Sales, Revenue Forecast 2022-2027
13.2 Global Hyperkalemia Treatment Forecast by Regions
13.2.1 Global Hyperkalemia Treatment Sales Forecast by Region 2022-2027
13.2.2 Global Hyperkalemia Treatment Revenue Forecast by Region 2022-2027
13.3 Global Hyperkalemia Treatment Forecast by Type
13.3.1 Global Hyperkalemia Treatment Sales Forecast by Type 2022-2027
13.3.2 Global Hyperkalemia Treatment Revenue Forecast by Type 2022-2027
13.3.3 Global Hyperkalemia Treatment Price Forecast by Type 2022-2027
13.4 Global Hyperkalemia Treatment Forecast by Application
13.4.1 Global Hyperkalemia Treatment Sales Forecast by Application 2022-2027
13.4.2 Global Hyperkalemia Treatment Revenue Forecast by Application 2022-2027
13.4.3 Global Hyperkalemia Treatment Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Hyperkalemia Treatment Production Specifications
Table 2: Drivers in Hyperkalemia Treatment Market
Table 3: Restraints Hyperkalemia Treatment Market
Table 4: Opportunity in Hyperkalemia Treatment Market
Table 5: Comparion of Alternative and Hyperkalemia Treatment
Table 6: Hyperkalemia Treatment Raw Materials Key Suppliers List
Table 7: Hyperkalemia Treatment Distributors List
Table 8: Hyperkalemia Treatment Major Buyers in Application One
Table 9: Hyperkalemia Treatment Major Buyers in Application Two
Table 10: Hyperkalemia Treatment Major Buyers in Application Three
Table 11: Global Hyperkalemia Treatment Sales (K Units) by Type 2016-2021
Table 12: Global Hyperkalemia Treatment Sales Market Share by Type 2016-2021
Table 13: Global Hyperkalemia Treatment Revenue (Million USD) by Type 2016-2021
Table 14: Global Hyperkalemia Treatment Revenue Market Share by Type 2016-2021
Table 15: Global Hyperkalemia Treatment Price by Type 2016-2021
Table 16: Global Hyperkalemia Treatment Sales (K Units) by Application 2016-2021
Table 17: Global Hyperkalemia Treatment Sales Market Share by Application 2016-2021
Table 18: Global Hyperkalemia Treatment Revenue (Million USD) by Application 2016-2021
Table 19: Global Hyperkalemia Treatment Revenue Market Share by Application 2016-2021
Table 20: Global Hyperkalemia Treatment Price by Application 2016-2021
Table 21: Global Hyperkalemia Treatment Sales (K Units) by Region 2016-2021
Table 22: Global Hyperkalemia Treatment Sales Market Share by Region 2016-2021
Table 23: Global Hyperkalemia Treatment Revenue (Million USD) by Region 2016-2021
Table 24: Global Hyperkalemia Treatment Revenue Market Share by Region 2016-2021
Table 25: North America Hyperkalemia Treatment Sales (K Units) by Country 2016-2021
Table 26: North America Hyperkalemia Treatment Sales Market Share by Country 2016-2021
Table 27: North America Hyperkalemia Treatment Revenue (Million USD) by Country 2016-2021
Table 28: North America Hyperkalemia Treatment Revenue Market Share by Country 2016-2021)
Table 29: Europe Hyperkalemia Treatment Sales (K Units) by Country 2016-2021
Table 30: Europe Hyperkalemia Treatment Sales Market Share by Country 2016-2021
Table 31: Europe Hyperkalemia Treatment Revenue (Million USD) by Country 2016-2021
Table 32: Europe Hyperkalemia Treatment Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Hyperkalemia Treatment Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Hyperkalemia Treatment Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Hyperkalemia Treatment Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Hyperkalemia Treatment Revenue Market Share by Country 2016-2021)
Table 37: South America Hyperkalemia Treatment Sales (K Units) by Country 2016-2021
Table 38: South America Hyperkalemia Treatment Sales Market Share by Country 2016-2021
Table 39: South America Hyperkalemia Treatment Revenue (Million USD) by Country 2016-2021
Table 40: South America Hyperkalemia Treatment Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Hyperkalemia Treatment Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Hyperkalemia Treatment Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Hyperkalemia Treatment Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Hyperkalemia Treatment Revenue Market Share by Country 2016-2021)
Table 45 Vifor Pharma Company Information
Table 46 Vifor Pharma Hyperkalemia Treatment Product Portfolio, Specification and Application
Table 47 Vifor Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sanofi Company Information
Table 49 Sanofi Hyperkalemia Treatment Product Portfolio, Specification and Application
Table 50 Sanofi Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 CMP Pharma Company Information
Table 52 CMP Pharma Hyperkalemia Treatment Product Portfolio, Specification and Application
Table 53 CMP Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Belcher Pharmaceuticals Company Information
Table 55 Belcher Pharmaceuticals Hyperkalemia Treatment Product Portfolio, Specification and Application
Table 56 Belcher Pharmaceuticals Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Astrazeneca Company Information
Table 58 Astrazeneca Hyperkalemia Treatment Product Portfolio, Specification and Application
Table 59 Astrazeneca Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Hyperkalemia Treatment Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Hyperkalemia Treatment Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Hyperkalemia Treatment Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Hyperkalemia Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Hyperkalemia Treatment Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Hyperkalemia Treatment Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Hyperkalemia Treatment Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Hyperkalemia Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Hyperkalemia Treatment Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Hyperkalemia Treatment Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Hyperkalemia Treatment Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Hyperkalemia Treatment Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Hyperkalemia Treatment Picture
Figure 2: Global Hyperkalemia Treatment Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Hyperkalemia Treatment Supply Chain Analysis
Figure 5: Hyperkalemia Treatment Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Patiromer
Figure 7: Product Picture of Sodium Zirconium Cyclosilicate
Figure 8: Global Hyperkalemia Treatment Sales Market Share by Type, 2020
Figure 9: Global Hyperkalemia Treatment Revenue Market Share by Type, 2020
Figure 10: Hyperkalemia Treatment in Hospital Pharmacy
Figure 11: Global Hyperkalemia Treatment Market: Hospital Pharmacy 2016-2021
Figure 12: Hyperkalemia Treatment in Retail Pharmacy
Figure 13: Global Hyperkalemia Treatment Market: Retail Pharmacy 2016-2021
Figure 14: Global Hyperkalemia Treatment Sales Market Share by Application, 2020
Figure 15: Global Hyperkalemia Treatment Revenue Market Share by Application, 2020
Figure 16: Global Hyperkalemia Treatment Sales Market Share by Region 2016-2021
Figure 17: Global Hyperkalemia Treatment Revenue Market Share by Region 2016-2021
Figure 18: North America Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 19: North America Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 20: Europe Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 21: Europe Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 24: South America Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 25: South America Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 28: North America Hyperkalemia Treatment Sales Market Share by Country, 2020
Figure 29: North America Hyperkalemia Treatment Revenue Market Share by Country, 2020
Figure 30: United States Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 31: United States Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 32: Canada Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 33: Canada Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 35: Mexico Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 36: Europe Hyperkalemia Treatment Sales Market Share by Country, 2020
Figure 37: Europe Hyperkalemia Treatment Revenue Market Share by Country, 2020
Figure 38: Germany Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 39: Germany Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 40: France Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 41: France Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 42: UK Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 43: UK Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 44: Italy Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 45: Italy Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 46: Russia Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 46: Russia Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 47: Spain Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 48: Spain Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Hyperkalemia Treatment Sales Market Share by Country, 2020
Figure 50: Asia Pacific Hyperkalemia Treatment Revenue Market Share by Country, 2020
Figure 51: China Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 52: China Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 53: Japan Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 54: Japan Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 55: Korea Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 56: Korea Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 59: India Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 60: India Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 61: Australia Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 62: Australia Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 63: South America Hyperkalemia Treatment Sales Market Share by Country, 2020
Figure 64: South America Hyperkalemia Treatment Revenue Market Share by Country, 2020
Figure 65: Brazil Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 66: Brazil Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 68: Argentina Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 70: Colombia Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Hyperkalemia Treatment Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Hyperkalemia Treatment Revenue Market Share by Country, 2020
Figure 73: Turkey Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 74: Turkey Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Hyperkalemia Treatment Sales (K Units) Status 2016-2021
Figure 78: South Africa Hyperkalemia Treatment Revenue (Million USD) Status 2016-2021
Figure 79: Vifor Pharma Hyperkalemia Treatment Revenue Market Share Globally (2019-2021)
Figure 80: Sanofi Hyperkalemia Treatment Revenue Market Share Globally (2019-2021)
Figure 81: CMP Pharma Hyperkalemia Treatment Revenue Market Share Globally (2019-2021)
Figure 82: Belcher Pharmaceuticals Hyperkalemia Treatment Revenue Market Share Globally (2019-2021)
Figure 83: Astrazeneca Hyperkalemia Treatment Revenue Market Share Globally (2019-2021)
Figure 89: Global Hyperkalemia Treatment Sales (K Units) Forecast (2022-2027)
Figure 90: Global Hyperkalemia Treatment Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets